MetLife Investment Management’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-73,099
| Closed | -$101K | – | 2791 |
|
2024
Q4 | $101K | Buy |
+73,099
| New | +$101K | ﹤0.01% | 2621 |
|
2024
Q3 | – | Sell |
-62,706
| Closed | -$108K | – | 2862 |
|
2024
Q2 | $108K | Buy |
62,706
+8,552
| +16% | +$14.8K | ﹤0.01% | 2566 |
|
2024
Q1 | $129K | Buy |
54,154
+1,024
| +2% | +$2.45K | ﹤0.01% | 2419 |
|
2023
Q4 | $177K | Hold |
53,130
| – | – | ﹤0.01% | 2301 |
|
2023
Q3 | $199K | Buy |
53,130
+14,239
| +37% | +$53.3K | ﹤0.01% | 2213 |
|
2023
Q2 | $166K | Hold |
38,891
| – | – | ﹤0.01% | 2388 |
|
2023
Q1 | $266K | Hold |
38,891
| – | – | ﹤0.01% | 2051 |
|
2022
Q4 | $308K | Hold |
38,891
| – | – | ﹤0.01% | 1966 |
|
2022
Q3 | $374K | Buy |
38,891
+4,003
| +11% | +$38.5K | ﹤0.01% | 1848 |
|
2022
Q2 | $253K | Hold |
34,888
| – | – | ﹤0.01% | 2148 |
|
2022
Q1 | $450K | Buy |
34,888
+13,564
| +64% | +$175K | ﹤0.01% | 1839 |
|
2021
Q4 | $340K | Hold |
21,324
| – | – | ﹤0.01% | 1727 |
|
2021
Q3 | $343K | Hold |
21,324
| – | – | ﹤0.01% | 1753 |
|
2021
Q2 | $295K | Hold |
21,324
| – | – | ﹤0.01% | 1901 |
|
2021
Q1 | $312K | Sell |
21,324
-7,082
| -25% | -$103K | ﹤0.01% | 1793 |
|
2020
Q4 | $494K | Hold |
28,406
| – | – | ﹤0.01% | 1505 |
|
2020
Q3 | $521K | Hold |
28,406
| – | – | 0.01% | 1349 |
|
2020
Q2 | $507K | Hold |
28,406
| – | – | 0.01% | 1369 |
|
2020
Q1 | $461K | Hold |
28,406
| – | – | 0.01% | 1261 |
|
2019
Q4 | $511K | Hold |
28,406
| – | – | 0.01% | 1451 |
|
2019
Q3 | $576K | Buy |
28,406
+5,934
| +26% | +$120K | 0.01% | 1342 |
|
2019
Q2 | $497K | Hold |
22,472
| – | – | 0.01% | 1484 |
|
2019
Q1 | $307K | Hold |
22,472
| – | – | ﹤0.01% | 1742 |
|
2018
Q4 | $203K | Hold |
22,472
| – | – | ﹤0.01% | 1900 |
|
2018
Q3 | $371K | Buy |
+22,472
| New | +$371K | ﹤0.01% | 1724 |
|